SMER28, a small-molecule enhancer of rapamycin (SMER), identified by chemical screening, was shown to induce mTOR-independent autophagy and to reduce mutant Huntington aggregates and A53T α-synuclein in cellular models of Huntington’s and Parkinson’s disease [25]. This evidence concerns the gene MTOR and Parkinson disease.